|
Consider Allogeneic Bone Marrow Transplantation for Older, Fit Patients with Aplastic Anemia
|
Jan 2019
|
Biol Blood Marrow Transplant
|
aplastic anemia
|
|
Considerations for Drug Development in Myelodysplastic Syndromes
|
Jul 2023
|
Clinical Cancer Research
|
myelodysplastic syndromes (MDS)
|
|
Content validity of patient-reported outcomes for use in lower-risk myelodysplastic syndromes
|
Aug 2020
|
Journal of Patient-Reported Outcomes
|
myelodysplastic syndromes (MDS)
|
|
Contribution of Revised International Prognostic Scoring System Cytogenetics to Predict Outcome After Allogeneic Stem Cell Transplantation for Myelodysplastic Syndromes: A Study From the French Society of Bone Marrow Transplantation and Cellular Therapy
|
Mar 2015
|
Transplantation
|
myelodysplastic syndromes (MDS)
|
|
Controversies on the Consequences of Iron Overload and Chelation in MDS
|
May 2020
|
HemaSphere
|
myelodysplastic syndromes (MDS)
|
|
Cord blood transplantation in aplastic anemia
|
Jan 2013
|
Bone Marrow Transplant
|
aplastic anemia
|
|
Costs and quality of life in patients with myelodysplastic syndromes.
|
Aug 2013
|
Am J Blood Res
|
myelodysplastic syndromes (MDS)
|
|
Cotransplantation of allogeneic mesenchymal and hematopoietic stem cells in children with aplastic anemia
|
May 2012
|
Pediatrics
|
aplastic anemia
|
|
Cotransplantation of bone marrow-derived mesenchymal stem cells in haploidentical hematopoietic stem cell transplantation in patients with severe aplastic anemia: an interim summary for a multicenter phase II trial results
|
Jan 2017
|
Bone Marrow Transplant
|
aplastic anemia
|
|
Counselling and adverse event management for patients with myelodysplastic syndromes undergoing azacitidine therapy: a practice standard for Canadian nurses
|
Oct 2012
|
Can Oncol Nurs J
|
myelodysplastic syndromes (MDS)
|
